This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

My Cart
Shopping Cart
0 items
£0.00
View Cart

Animal Pharm - Medicines for Aquaculture 2016

£2,250.00

Availability: In stock

SKU: 83647

Quick Overview

Diseases; Diagnostics; Pharmaceuticals; Vaccines

You may also be interested in ...

Product Overview

The fast-growing aquaculture health industry is of increasing interest to the mainstream animal health sector. This is demonstrated by the entry and expansion of the big global players into this market i.e. MSD, Elanco and Zoetis among others. It is estimated to be worth around US$500 million already.

This Animal Pharm report is the first to cover the aquaculture medicines market segment in depth. A wide range of diseases affect fish and shrimp production and these are described in the report, together with the latest research on aetiology, diagnosis, prevention and treatment. The causes include viruses, bacteria, ecto- and endo- parasites, and fungi.

Available pharmaceuticals are described including antimicrobials, probiotics, bacteriophages, immunostimulants, antiparasitics etc. and there is a separate chapter on vaccines for viral and bacterial disease, fish vaccine administration and specialised techniques including oral, nasal administration and novel delivery systems.

The final chapter revisits some of the problem issues for the industry and suggest how these are being addressed now and in the future. Regulatory issues such as GM salmon, problems with medication, the environment, public health and welfare are fully discussed.

Format: PDF Report sent by email

PLEASE NOTE: Price now includes access for three users. For additional users, please email reports@agri.informa.com

Features & Contents

Click here for contents pages

Click here for the executive summary

Click here for sample pages

More Info

Professor Andy Peters is a Director of ARPEXAS Ltd., an animal health consultancy, providing support to the industry and academia in strategies for new product development, with special emphasis on vaccines and diagnostics in both developed and developing countries. Until December 2005 he was Head of European Vaccine R&D with Pfizer Animal Health. Between 1993 and 1998 he was Professor of Animal Health and Production at the Royal Veterinary College, London. He is a veterinarian with PhD and DSc degrees in animal science and currently holds a special professorship with the University of Nottingham. He is also the author of previous Animal Pharm reports on Veterinary Vaccines and Diagnostics for Veterinary Infectious Diseases.

Reviews (0)

There are no reviews for this product yet. Be the first to share your experiences.